| 3.02 Delayed Data As of Feb 21 |  -0.03 / -0.98%Today’s Change | 2.53 Today|||52-Week Range 7.57 | +7.09% Year-to-Date |
| Previous close | 3.05 |
| Today’s open | 3.09 |
| Day’s range | 3.00 - 3.12 |
| Volume | 759,008 |
| Average volume (3 months) | 1,756,534 |
| Market cap | $371.4M |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +2,067,803.02% |
| P/E ratio | -- |
| Price/Sales | 0.97 |
| Price/Book | 1.18 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $39.4M |
| Annual profit (last year) | -$66.1M |
| Net profit margin | -167.53% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Adam Bierman |
President & Director Andrew Modlin |
Corporate headquarters Culver City, California |
